Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization

Journal of General Virology

Volumn 80, Issue 8, 1999, Pages 2183-2191

  Speckner, Andrea ^a   Glykofrydes, Diana ^a   Ohlin, Mats ^b   Mach, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS ANTIGEN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANTIGEN BINDING; ARTICLE; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0032802172     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-8-2183     Document Type: Article

References (45)

1. Adler, S. P., Starr, S. E., Plotkin, S. A., Hempfling, S. H., Buis, J., Manning, M. L. & Best, A. M. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. Journal of Infectious Diseases 171, 26-32.
2. Bonci, A., Bracci, L., Caudai, C., Lozzi, L., Moschettini, D., Niccolai, N., Scarselli, M., Valensin, P. E. & Neri, P. (1993). Characterization of immunoreactive octapeptides of human-cyromegalovirus gp58. European Journal of Biochemistry 215, 383-387.
3. Britt, W. J. (1984). Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135, 369-378.
4. Britt, W. J. & Vugler, L. G. (1989). Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. Journal of Virology 63, 403-410.
5. Britt, W. J. & Vugler, L. G. (1992). Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). Journal of Virology 66, 6747-6754.
6. Britt, W. J., Vugler, L., Butfiloski, E. J. & Stephens, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64, 1079-1085.
7. Chou, S. W. & Dennison, K. M. (1991). Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. Journal of Infectious Diseases 163, 1229-1234.
8. Darlington, J., Super, M., Patel, K., Grundy, J. E., Griffiths, P. D. & Emery, V. C. (1991). Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. Journal of General Virology 72, 1985-1989.
9. Dimmock, N. J. (1984). Mechanisms of neutralization of animal viruses. Journal of General Virology 65, 1015-1022.
10. Dimmock, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology and Immunology 183, 1-149.
11. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. & Alford, C. A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [see comments]. New England Journal of Medicine 326, 663-667.
12. Gonczol, E., deTaisne, C., Hirka, G., Berencsi, K., Lin, W. C., Paoletti, E. & Plotkin, S. (1991). High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity. Vaccine 9, 631-637.
13. Ho, M. (1992). Cytomegalovirus. Biology and Infection, 2nd edn. New York: Plenum.
14. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179, 1713-1717.
15. Kari, B. & Gehrz, R. (1991). Biochemical and immunological analysis of discontinuous epitopes in the family of human cytomegalovirus glycoprotein complexes designated gC-I. Journal of General Virology 72, 1975-1983.
16. Kari, B., Liu, Y. N., Goertz, R., Lussenhop, N., Stinski, M. F. & Gehrz, R. (1990). Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). Journal of General Virology 71, 2673-2680.
17. Klein, M., Schoppel, K., Amvrossiadis, N. & Mach, M. (1999). Strain-specific neutralization of human cytomegalovirus isolates by human sera. Journal of Virology 73, 878-886.
18. Kniess, N., Mach, M., Fay, J. & Britt, W. J. (1991). Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. Journal of Virology 65, 138-146.
19. Kropff, B. & Mach, M. (1997). Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein. Journal of General Virology 78, 1999-2007.
20. Kropff, B., Landini, M. P. & Mach, M. (1993). An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus. Journal of Medical Virology 39, 187-195.
21. Lehner, R., Stamminger, T. & Mach, M. (1991). Comparative sequence analysis of human cytomegalovirus strains. Journal of Clinical Microbiology 29, 2494-2502.
22. Lussenhop, N. O., Goertz, R., Wabuke-Bunoti, M., Gehrz, R. & Kari, B. (1988). Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology 164, 362-372.
23. Mach, M., Utz, U. & Fleckenstein, B. (1986). Mapping of the major glycoprotein gene of human cytomegalovirus. Journal of General Virology 67, 1461-1467.
24. Marshall, G. S., Rabalais, G. P., Stout, G. G. & Waldeyer, S. L. (1992). Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. Journal of Infectious Diseases 165, 381-384.
25. Meyer, H., Masuho, Y. & Mach, M. (1990). The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. Journal of General Virology 71, 2443-2450.
26. Meyer, H., Sundqvist, V.-A., Pereira, L. & Mach, M. (1992). Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73, 2375-2383.
27. Myers, R. M. (1989). Region-specific mutagenesis. In Current Protocols in Molecular Biology, unit 8.3. Edited by F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman & K. Struhl. New York: John Wiley.
28. Myers, R. M., Lerman, L. S. & Maniatis, T. (1985). A general method for saturation mutagenesis of cloned DNA fragments. Science 229, 242-247.
29. Ohlin, M., Sundqvist, V. A., Mach, M., Wahren, B. & Borrebaeck, C. A. (1993). Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. Journal of Virology 67, 703-710.
30. Qadri, I., Navarro, D., Paz, P. & Pereira, L. (1992). Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. Journal of General Virology 73, 2913-2921.
31. Rapp, M., Messerle, M., Lucin, P. & Koszinowski, U. H. (1993). In vivo protection studies with MCMV glycoproteins gB and gH expressed by vaccinia virus. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease, pp. 327-332. Edited by S. Michelson & S. A. Plotkin. Amsterdam: Excerpta Medica.
32. Reddehase, M. J., Batthesen, M., Rapp, M., Jonjic, S., Pavic, I. & Koszinowski, U. H. (1994). The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. Journal of Experimental Medicine 179, 185-193.
33. Roy, D. M., Grundy, J. E. & Emery, V. C. (1993). Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients. Journal of General Virology 74, 2499-2505.
34. Schoppel, K., Hassfurther, E., Britt, W. J., Ohlin, M., Borrebaeck, C. A. & Mach, M. (1996). Antibodies specific for the antigenic domain 1 (AD-1) of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures. Virology 216, 133-145.
35. Schoppel, K., Kropff, B., Schmidt, C., Vornhagen, R. & Mach, M. (1997). The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein specific antibodies. Journal of Infectious Diseases 175, 533-544.
36. Spindler, K. R., Rosser, D. S. & Berk, A. J. (1984). Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. Journal of Virology 49, 132-141.
37. Starr, S. E., Friedman, H. M. & Plotkin, S. A. (1991). The status of cytomegalovirus vaccine. Reviews of Infectious Diseases 13(Suppl. 11), S964-S965.
38. Tanaka, A., Moriuchi, H., Hirota, K. & Numazaki, Y. (1991). Neutralizing antibody response to cytomegalovirus in seropositive pregnant women. Journal of Medical Virology 34, 85-88.
39. Urban, M., Britt, W. & Mach, M. (1992). The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. Journal of Virology 66, 1303-1311.
40. Urban, M., Winkler, T., Landini, M. P., Britt, W. & Mach, M. (1994). Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. Journal of Infectious Diseases 169, 83-90.
41. Urban, M., Klein, M., Britt, W. J., Hassfurther, E. & Mach, M. (1996). Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. Journal of General Virology 77, 1537-1547.
42. Utz, U., Britt, W., Vugler, L. & Mach, M. (1989). Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63, 1995-2001.
43. Wagner, B., Kropff, B., Kalbacher, H., Britt, W., Sundqvist, V. A., Ostberg, L. & Mach, M. (1992). A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. Journal of Virology 66, 5290-5297.
44. Wang, J. B., Adler, S. P., Hempfling, S., Burke, R. L., Duliege, A. M., Starr, S. E. & Plotkin, S. A. (1996). Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines. Journal of Infectious Diseases 174, 387-392.
45. Werner, B. G., Snydman, D. R., Freeman, R., Rohrer, R., Tilney, N. L. & Kirkman, R. L. (1993). Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. Transplantation Proceedings 25, 1441-1443.